Encompass Health Corp [EHC] stock is trading at $112.67, up 0.60%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EHC shares have lost -2.53% over the last week, with a monthly amount drifted -10.01%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $115. Previously, Leerink Partners started tracking the stock with Outperform rating on July 10, 2024, and set its price target to $100. On March 06, 2024, Barclays initiated with an Overweight rating and assigned a price target of $95 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $57 on March 14, 2023. UBS initiated its recommendation with a Buy and recommended $98 as its price target on September 24, 2021. Raymond James upgraded its rating to Strong Buy for this stock on August 02, 2021, and upped its price target to $107. In a note dated November 23, 2020, Barclays upgraded an Overweight rating on this stock but restated the target price of $96.
Encompass Health Corp [EHC] stock has fluctuated between $87.85 and $127.99 over the past year. Currently, Wall Street analysts expect the stock to reach $146.67 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $112.67 at the most recent close of the market. An investor can expect a potential return of 30.18% based on the average EHC price forecast.
Analyzing the EHC fundamentals
Encompass Health Corp [NYSE:EHC] reported sales of 5.80B for the trailing twelve months, which represents a growth of 9.36%. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.22 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 111.99 points at the first support level, and at 111.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 113.24, and for the 2nd resistance point, it is at 113.81.
Ratios To Look Out For
For context, Encompass Health Corp’s Current Ratio is 1.14. Also, the Quick Ratio is 1.14, while the Cash Ratio stands at 0.06. Considering the valuation of this stock, the price to sales ratio is 1.96, the price to book ratio is 4.78 and price to earnings (TTM) ratio is 21.29.
Transactions by insiders
Recent insider trading involved Tuer Patrick William, EVP, Chief Operating Officer, that happened on Aug 27 ’25 when 1020.0 shares were sold. Officer, Patrick Tuer completed a deal on Aug 27 ’25 to buy 1020.0 shares. Meanwhile, President & CEO Tarr Mark J sold 0.12 million shares on May 20 ’25.
